Lloyds Engineering Works Partners with The Materials Works for Exclusive Production of EPS Gen 4 Cells

Lloyds Engineering Works Limited has entered into a strategic international technology partnership to bring next-generation, environmentally sustainable steel surface processing to its global manufacturing footprint.
Key Development
The company has signed a purchase and licensing agreement with US-based The Material Works Limited (TMW), giving Lloyds Engineering the right to design, manufacture and sell TMW’s patented Eco Pickled Surface (EPS) Generation 4 steel processing cells across most global markets.
Under the agreement, Lloyds will have exclusive commercial rights to this technology worldwide, excluding China, Hong Kong, Macau, Taiwan and a 350-mile radius around TMW’s base in Illinois, USA.
EPS Gen 4 is a proprietary acid-free steel surface treatment process that replaces conventional pickling methods, which typically rely on acids that generate hazardous waste and environmental pollution. The technology allows steel surfaces to be cleaned using recyclable materials with zero liquid effluent, significantly reducing environmental impact.
Business Insights
As part of the agreement, TMW will provide Lloyds Engineering with access to its patented technology, continuous design upgrades, technical training, marketing support and sales enablement.
Lloyds will make agreed earn-out payments in cash over a defined period, while retaining the right to manufacture and sell an unlimited number of EPS Gen 4 cells using the licensed technology.
The partnership is structured as a licensing arrangement rather than an equity acquisition and does not involve any related-party interests.
Lloyds Engineering Works Share Price Performance
As of January 12, 2025, at 9:20 AM, Lloyds Engineering share price is trading at ₹50.80 per share, reflecting a decline of 0.39% from the previous closing price.
Conclusion
The licensing deal with The Material Works gives Lloyds Engineering a strong technological edge in clean steel processing, opening up a high-value global opportunity in eco-friendly industrial equipment.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 12, 2026, 12:32 PM IST

Team Angel One
- Alembic Pharmaceuticals Share Price in Focus; US FDA Issues Form 483 With No Observations for Bioequivalence Unit in Gujarat
- Adani Ports Share Price in Focus; Receives SEBI Settlement Order Concerning Former Executives
- Glenmark Pharmaceuticals Share Price in Focus; Launches RYALTRIS Nasal Spray in Brazil
- Premier Energies Share Price in Focus; Unit Enters Binding Term Sheet for JV with RCT Energy India
- Mphasis Share Price in Focus; Partners with SGBS Unnati Foundation for Greener Bengaluru


